Myriad Genetics, Inc. (MYGN) P/E ratio

P/E ratio · fiscal 2019
463.0×

The P/E ratio of Myriad Genetics, Inc. (MYGN) was 463.0× at the end of fiscal 2019 (June 30, 2019). That is 2192.1% higher than the 20.2× of fiscal 2018. Figures as of 18 Nov 2026, 11:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio, fiscal 2019
463.0×
Change on fiscal 2018
+2192.1%
Highest on record
463.0×fiscal 2019
Lowest on record
9.7×fiscal 2010
Fiscal years on record
112009–2019

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Myriad Genetics, Inc. P/E ratio, in more detail

Across the 11 fiscal year-ends on record (2009–2019), the highest was 463.0× in fiscal 2019 and the lowest 9.7× in fiscal 2010.

History · 11 fiscal years

P/E ratio at each fiscal year-end

Myriad Genetics, Inc. P/E ratio, year by year

Myriad Genetics, Inc. (MYGN) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$6.15-$3.95
2024——$13.71-$1.41
2023——$19.14-$3.18
2022——$14.51-$1.39
2021——$27.60-$0.35
2020——$19.77-$2.99
2020——$11.34-$2.69
2019463.0× 2,192.1% up$27.78$0.06
201820.2× 80.5% down$37.37$1.85
2017103.4× 440.4% up$25.84$0.25
201619.1× 39.8% down$30.60$1.60
201531.8× 83.6% up$33.99$1.07
201417.3× 13.9% up$38.92$2.25
201315.2× 17.0% down$26.87$1.77
201218.3× 11.4% down$23.77$1.30
201120.6× 112.7% up$22.71$1.10
20109.7× 76.6% down$14.95$1.54
200941.5×—$35.65$0.86

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on MYGN

Myriad Genetics, Inc., figure by figure

Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard

Myriad Genetics, Inc. P/E ratio: questions and answers

What is Myriad Genetics, Inc.'s P/E ratio?

The P/E ratio of Myriad Genetics, Inc. (MYGN) was 463.0× at the end of fiscal 2019 (June 30, 2019). That is 2192.1% higher than the 20.2× of fiscal 2018.

What are the highest and lowest P/E ratio figures on record for Myriad Genetics, Inc.?

Across the 11 fiscal year-ends on record (2009–2019), the highest was 463.0× in fiscal 2019 and the lowest 9.7× in fiscal 2010.

How is Myriad Genetics, Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Myriad Genetics, Inc. it is on record here for 11 fiscal years, 2009 to 2019.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Myriad Genetics, Inc. (MYGN) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.